Photo of Abe Clark

View Scopus Profile

Abe Clark, PhD

  • 10616 Citations
  • 56 h-Index
1979 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Area of Expertise

Dr. Clark’s major research focus is to discover the molecular mechanisms involved in ocular diseases, particularly glaucoma, in order to develop disease modifying therapies for better management of ocular diseases. Glaucoma is the leading cause of irreversible vision loss and blindness in the world and is also the leading neurodegenerative disease, affecting both the eye and brain. Dr. Clark’s research includes molecular genetics, molecular biology, cell biology, physiology, pathology, and mouse models of glaucoma. A main goal in this lab is to perform translational research that eventually will help patients with glaucoma. In addition to research, he trains and mentors graduate students, postdoctoral fellows, and medical students. He also is very active in community-based vision screening events.

Education/Academic qualification

PhD in Microbiology, Case Western Reserve University

Award Date: 1 Jan 2002

BA in Biology, Thiel College

Award Date: 1 Jan 2001

Fingerprint Dive into the research topics where Abe Clark is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

VisiPlate Pilot: Perfused Human Cadaver Eyes

Clark, A.

Avisi Technologies

24/09/19 → 23/09/20

Project: Research

Novel Genome Editing for the Treatment of Glaucoma

Clark, A.

University of Iowa

1/07/19 → 30/04/20

Project: Research

Evaluation of NAC, NACA and diNACA in Cultured RPE Cells and in Cultured Corneal Endothelial Cells (CECs) +/- Oxidative Stress

Clark, A. & Wu, H. (.

Nacuity Pharmaceuticals, Inc.

18/02/19 → 4/06/20

Project: Research

Glucocorticoids, Ocular Hypertension, and Glaucoma

Clark, A. & Millar, C.

NEI: National Eye Institute

30/09/18 → 31/08/19

Project: Research

Preclinical Evaluation of Graybug Vision Compound

Clark, A., Tovar-Vidales, T., Liu, Y. & Millar, C.

Graybug Vision, Inc.

5/06/17 → 4/06/19

Project: Research

Research Output

Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma

Daniel, S., Meyer, K. J., Clark, A. F., Anderson, M. G. & McDowell, C. M., Aug 2019, In : Experimental eye research. 185, 107703.

Research output: Contribution to journal › Article

    • Glucocorticoid receptor transactivation is required for glucocorticoid-induced ocular hypertension and glaucoma

    Patel, G. C., Millar, J. C. & Clark, A. F., May 2019, In : Investigative Ophthalmology and Visual Science. 60, 6, p. 1967-1978 12 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Inducible rodent models of glaucoma

    Pang, I. H. & Clark, A. F., 1 Jan 2019, (Accepted/In press) In : Progress in Retinal and Eye Research. 100799.

    Research output: Contribution to journal › Article

    • RE: “Letter to the Editor concerning Webber et al. Exp Eye Res. 148:97–102, 2016”

    Webber, H. C., Bermudez, J. Y., Sethi, A., Clark, A. F. & Mao, W., Jan 2019, In : Experimental eye research. 178, 1 p.

    Research output: Contribution to journal › Letter

    Activation of the NFAT-calcium signaling pathway in human lamina cribrosa cells in glaucoma

    Irnaten, M., Zhdanov, A., Brennan, D., Crotty, T., Clark, A., Papkovsky, D. & O’Brien, C., Feb 2018, In : Investigative Ophthalmology and Visual Science. 59, 2, p. 831-842 12 p.

    Research output: Contribution to journal › Article

    • 9 Scopus citations